Clinical Trial Update: Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating efficacy and safety for treatment of house dust mite–induced allergic asthma and perennial allergic rhinitis/rhinoconjunctivit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma
• Allergic Rhinoconjunctivitis
• House Dust Mite Allergy
• Perennial Allergic Rhinitis

Snippet

Sponsor: Inmunotek S.L. | Conditions: House Dust Mite Allergy, Perennial Allergic Rhinitis | Phase 3 | Status: UNKNOWN